Part 4 of 4 (Series on Oncology)

Introduction

In cancer cells, calcium signaling is a critical regulator of metabolic processes that support cell survival. It specifically enhances the activity of TCA cycle enzymes, such as isocitrate dehydrogenase and oxoglutarate dehydrogenase, which are vital for producing the metabolic intermediates required for rapid proliferation. Beyond its metabolic support, calcium is essential for maintaining mitochondrial membrane potential and preventing apoptosis. Additionally, calcium is crucial in activating calmodulin-dependent kinases, directly influencing key signaling pathways governing cell cycle progression and resistance to apoptosis.

AIC Therapy can induce apoptosis by activating caspases and modulating these calcium-dependent pathways. This disruption of calcium homeostasis also increases cancer cells' susceptibility to oxidative stress, mainly through regulating reactive oxygen species (ROS) production within the mitochondria. The ability of AIC Therapy to influence these critical mechanisms shows its potential as a therapeutic agent, targeting cancer cells' metabolic and survival pathways.

Cancer cells often exhibit overactive calcium channels, which play a crucial role in their uncontrolled proliferation, survival, migration, invasion, and metastasis by regulating the cell cycle, avoiding apoptosis, and enhancing cytoskeletal dynamics and cell adhesion. When these overactive channels are overstimulated, such as through increased calcium influx, it can lead to mitochondrial dysfunction and apoptosis. AIC Therapy interacts with these channels, leading to excessive calcium influx in cancer cells. In contrast, normal cells, which do not exhibit these overactive channels, are not subjected to calcium overload. Instead, AIC Therapy restores calcium homeostasis in normal cells without inducing cell death.

Calcium plays a crucial role in the metabolism and survival of cancer cells, particularly by enhancing the activity of key enzymes in the tricarboxylic acid (TCA) cycle and maintaining mitochondrial membrane potential. Because calcium activates calmodulin-dependent kinases essential for cancer cell survival, altering calcium signaling can disrupt cancer cell viability. Therefore, restoring calcium signaling within cancer cells by AIC Therapy can induce apoptosis by activating caspases and increase their susceptibility to oxidative stress by regulating reactive oxygen species (ROS) production.

Figure 1 
This figure shows the critical role of calcium in the metabolic reprogramming of cancer cells. Calcium influx into the mitochondria regulates key enzymes within the TCA cycle, supporting ATP production and overall cellular metabolism essential for tumor survival and proliferation. The mitochondria-associated membranes serve as crucial sites where calcium dynamics are tightly controlled, with proteins like hexokinase 2 binding to voltage-dependent anion channels to prevent pro-apoptotic factor release. Disruption of this calcium homeostasis, such as through calcium overload, can lead to mitochondrial dysfunction and induce apoptosis. This intricate regulation of calcium within the mitochondria represents a potential therapeutic target for disrupting cancer cell survival mechanisms.

Inducing Apoptosis through Mitochondrial Dysfunction

Calcium’s precise regulation within cancer cells is pivotal in sustaining their metabolic functions and preventing apoptosis. Also, the tight regulation of calcium across mitochondrial and endoplasmic reticulum membranes plays a crucial role in supporting tumor growth and survival. Disrupting this balance could make cancer cells more vulnerable to treatments, mainly by inducing apoptosis through mitochondrial dysfunction. AIC Therapy leverages these insights, offering a promising approach to cancer treatment by targeting these critical calcium-dependent pathways.

Figure 2 

This figure shows how calcium signaling contributes to the inhibition of apoptosis in cancer cells. Increased calcium influx through upregulated channels on the plasma membrane activates key pathways that inhibit the action of pro-apoptotic proteins, particularly caspases 8 and 9. Additionally, the downregulation of specific channels and transporters within the endoplasmic reticulum and mitochondria results in decreased internal calcium levels, further preventing apoptosis. The overall effect is the survival and continued proliferation of cancer cells due to the suppression of programmed cell death mechanisms.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10951838/

Clinical Case 1

A 53-year-old woman presented with a diagnosis of intraductal carcinoma, stage 3a, which was estrogen receptor (ER) and progesterone receptor (PR) negative but HER2 positive. A contrast-enhanced CT scan revealed a 4.1 cm mass in the lower outer quadrant of the right breast, along with the involvement of four axillary lymph nodes. The patient was treated with dietary modification and AIC Therapy, taken three times a day for two weeks before surgery. After this treatment, a lumpectomy and axillary clearance were performed, and biopsy results showed that the tumor size had reduced to 1.3 cm with no lymph node involvement. As a result, the cancer was downstaged to stage 1a, indicating a significant reduction in the severity of the disease.

Clinical Case 2

A 42-year-old woman, Para 3, presented with a six-month history of irregular menstrual bleeding and intermenstrual spotting. She had been consuming animal-derived placenta for a year before the onset of symptoms and had no other underlying medical conditions. Blood tests revealed a slightly elevated ESR and a CA-125 level of 56, while a pelvic ultrasound identified a clear, simple ovarian cyst measuring 4x3 cm on the right ovary. The patient refused surgery and was treated with AIC, taken three times a day for two months. After AIC Therapy, her CA-125 level normalized, the ovarian cyst completely resolved, and her menstrual cycles returned to normal.

Conclusion

AIC Therapy effectively targets and disrupts the critical calcium-dependent pathways that cancer cells rely on for survival and proliferation. Clinical results confirm its practical benefits in treating cancer, including significant tumor reduction and the resolution of cancer-related symptoms. By modulating calcium dynamics within cancer cells, AIC Therapy provides a precise and targeted approach to treating cancer and improving patient outcomes.

We offer free 25-minute Zoom consultation sessions for practitioners wanting to know more about AIC Therapy.

Join our community today and get instant access to cutting-edge research on AIC Therapy for your patient’s treatments. Thank you for reading.

Server Bozdogan MD, PhD. - ACRI Research Director

Read about More Benefits of AIC Therapy

AIC delivered me from the last stage of prostate and colon cancer. After eight years, I am still cancer-free!

In March of 2010, at the age of 60, I was diagnosed with prostate cancer, which had spread to the large colon. I had to remove the tumor from it surgically. One day in early July, I wrote up my last will for my children and family. I also stopped by Dr. Lee's lab to bid farewell, as we have been friends for a while, and he introduced me to AIC and recommended I take it. I did not know what it was, but I brought it home and took it as instructed. Up until that moment, because of prostate cancer, I couldn't urinate properly, which made urination very uncomfortable and difficult. However, after taking AIC, I was able to urinate as if I were free from prostate cancer. Dr. Lee encouraged me to take AIC 3-4 times daily. A month later, to my disbelief, my blood test result indicated that my PSA levels dropped from 28 to 4, and I also felt great physically.

On August 20, I was getting ready to have ostomy surgery. Following my doctor's recommendation, I could not help it, though the thought of it made me cringe. Arriving at the hospital on the day of surgery, Dr. Lee was there to pray for me. He left as I was escorted into the operation room for the procedure. However, when I woke up from anesthesia and realized that I had no ostomy bag on my belly, I was confused. I asked if the operation had not started yet or if there were any complications. The surgeon replied that there was no need to remove the rectum! Hallelujah! I could not believe my ears and immediately informed Dr. Lee, who was as happy as I was. In January 2012, I had another blood test, and the result came out normal with no traces of cancer. It felt like a dream. I am so thankful for Dr. Lee's development of AIC.

In January 2020, I am still healthy with no cancer!"

Mr. Cho, Male, 68, Surrey, BC, Canada

Scoliosis surgery postponed after AIC treatment

A Doctor's Anecdotal Note: My patient, age 60, has severe scoliosis of the spine and is seen by many spinal surgeons who insist she must have surgery to put in plates and screws to prevent further collapse of the spine.
As she was already menopause, she would also need a Prolia injection every 6 months to increase her bone density so that the screws would not be loosened.
Her surgery was scheduled for January 2019.
I started her on AIC in October last year.
Surprisingly, she could feel her spine stronger after only 1 week.
She has canceled her operation and introduced her sister to AIC

Anonymous -- Age 60, female, Singapore

Disclaimer

The information provided in this newsletter is intended for educational and informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment options. Never disregard professional medical advice or delay seeking it because of something you have read in this newsletter. This newsletter does not endorse or recommend any specific treatments, medications, or procedures. Discussing disease conditions and treatment options is based on general information and does not consider individual circumstances. The authors and publishers of this newsletter are not responsible for any adverse effects or consequences resulting from using any suggestions or information contained in the newsletter. Always consult with a healthcare professional before starting any new treatment or changing your existing treatment plan.